EcoDrugPlus

Ensembl ID : ENSDNOG00000048119
Gene Symbol: -
1 Cross references
139 Possible Orthologues:

Ensembl ID : ENSDNOG00000049278
Gene Symbol: -
1 Cross references
134 Possible Orthologues:

Ensembl ID : ENSDNOG00000049371
Gene Symbol: -
1 Cross references
257 Possible Orthologues:

Ensembl ID : ENSDNOG00000039117
Gene Symbol: -
1 Cross references
121 Possible Orthologues:

Ensembl ID : ENSDNOG00000038925
Gene Symbol: -
1 Cross references
290 Possible Orthologues:

Ensembl ID : ENSDNOG00000038463
Gene Symbol: -
1 Cross references
276 Possible Orthologues:

Ensembl ID : ENSDNOG00000038203
Gene Symbol: -
1 Cross references
243 Possible Orthologues:

Ensembl ID : ENSDNOG00000037697
Gene Symbol: -
1 Cross references
214 Possible Orthologues:

Ensembl ID : ENSDNOG00000049590
Gene Symbol: -
1 Cross references
260 Possible Orthologues:

Ensembl ID : ENSDNOG00000035437
Gene Symbol: -
1 Cross references
177 Possible Orthologues:

Ensembl ID : ENSDNOG00000035340
Gene Symbol: -
1 Cross references
290 Possible Orthologues:

Ensembl ID : ENSDNOG00000049087
Gene Symbol: -
1 Cross references
285 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).